First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories

NCT05340790 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Colpomycosis
Bacterial Vaginosis
Mixede Vaginitis

Interventions

DRUG: Dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories
DRUG: Placebo dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories

Sponsor

Protelight Pharmaceuticals Australia PTY LTD